Hugh M. Davis
President, COO & DirectorDr. Hugh M. Davis, Ph.D., is Advisory Board Member of Biosion, Inc from November 2024. Dr. Davis is President and Chief Operating Officer of Aclaris Therapeutics, Inc. from November 18, 2024 and serves as its Director since November 2024. He joined Aclaris Therapeutics, Inc. in November 2024. He served as Chief Business & Development Officer and President of Biosion USA at Biosion, Inc. since 2023 and was its Chief Operating Officer. He was the Chief Business Officer of the Frontage Holdings Corporation since April 2018, responsible for sales, marketing, business development and strategic alliances. From 2001 to 2018, he worked at Janssen Research & Development, LLC, holding various management positions. In particular, from February 2004, he was the vice president of Clinical Pharmacology. He was the vice president and head of biologics Development Sciences. He worked at GSK and Johnson & Johnson. He has held professional positions at several academic institutions including Villanova University, chemistry department as an adjunct professor since September 1984. He is also a member of the Dean’s Advisory Council for the College of Liberal Arts and Sciences at Villanova University. Dr. Davis received his bachelor ’s of science from Gannon University, United States, in May 1980 and his PhD degree in Biochemistry from Villanova University, United States, in December 1985. He received his M.S. degrees in Biochemistry from Villanova University.
Positions
- Company NameAclaris Therapeutics, Inc.Stock CodeACRSPositionPresident, COO & Director
